COSA 2022: Avelumab Improves Survival in Advanced Urothelial Carcinoma After Chemotherapy
Treatment is effective in all patients who do not progress after chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.